Ys Biopharma Co, Stock Price To Sales
| YSDelisted Stock | 0.48 0.03 5.88% |
YS Biopharma Co, fundamentals help investors to digest information that contributes to YS Biopharma's financial success or failures. It also enables traders to predict the movement of YS Biopharma Stock. The fundamental analysis module provides a way to measure YS Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to YS Biopharma stock.
YS Biopharma |
YS Biopharma Co, Company Price To Sales Analysis
YS Biopharma's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current YS Biopharma Price To Sales | 0.29 X |
Most of YS Biopharma's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, YS Biopharma Co, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, YS Biopharma Co, has a Price To Sales of 0.2888 times. This is 98.65% lower than that of the Biotechnology sector and 99.71% lower than that of the Health Care industry. The price to sales for all United States stocks is 97.47% higher than that of the company.
YS Biopharma Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses YS Biopharma's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of YS Biopharma could also be used in its relative valuation, which is a method of valuing YS Biopharma by comparing valuation metrics of similar companies.YS Biopharma is currently under evaluation in price to sales category among its peers.
YS Biopharma Fundamentals
| Return On Equity | -0.78 | |||
| Return On Asset | -0.1 | |||
| Profit Margin | (0.67) % | |||
| Operating Margin | (0.49) % | |||
| Current Valuation | 429.47 M | |||
| Shares Outstanding | 188.33 M | |||
| Shares Owned By Insiders | 81.42 % | |||
| Shares Owned By Institutions | 2.85 % | |||
| Number Of Shares Shorted | 38.89 K | |||
| Price To Book | 2.10 X | |||
| Price To Sales | 0.29 X | |||
| Revenue | 687.2 M | |||
| EBITDA | (76.82 M) | |||
| Net Income | (145.48 M) | |||
| Total Debt | 498.63 M | |||
| Book Value Per Share | 5.10 X | |||
| Cash Flow From Operations | (182.47 M) | |||
| Short Ratio | 0.31 X | |||
| Earnings Per Share | (0.56) X | |||
| Target Price | 4.17 | |||
| Number Of Employees | 773 | |||
| Beta | 0.54 | |||
| Market Capitalization | 192.09 M | |||
| Total Asset | 1.72 B | |||
| Retained Earnings | (1.87 B) | |||
| Working Capital | 377.22 M | |||
| Net Asset | 1.72 B |
About YS Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze YS Biopharma Co,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of YS Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of YS Biopharma Co, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in YS Biopharma Stock
If you are still planning to invest in YS Biopharma Co, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the YS Biopharma's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |